← Back to all trials
Recruiting
NCT05687253
Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery
Conditions: Neuromuscular Blockade, Anesthesia, Surgery
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: 1
Phase: PHASE2
Enrollment: 80
Sponsor: Baudax Bio
Location: United States
Summary
Assessment of Intubation conditions following administration of neuromuscular blocking agents; BX1000 (investigational) or rocuronium (active control).
Eligibility Criteria
Inclusion Criteria:Providing informed consentUndergoing elective surgery utilizing IV general anesthesiaNormal airway assessmentExclusion Criteria:Unstable disease or emergency surgical conditionsKnown hypersensitivity to rocuronium, other NMB or study medicationsHistory of anaphylaxisHistory of neuromuscular junction diseasePersonal or family history of malignant hyperthermia or pseudocholinesterase deficiencyDiagnosed or suspected sleep apneaHistory of prior anesthetic complications
Source: ClinicalTrials.gov (NCT05687253). StuddyBuddy aggregates publicly available trial information.
